Alicia C Olivo Neogenomics Inc (NEO) insider trading activity

Alicia C Olivo is EVP, GC & Business Development of NEOGENOMICS INC. Currently has a direct ownership of 75,320 shares of NEO, which is worth approximately $778,808. The most recent transaction as insider was on Jan 13, 2026, when has been sold 15,145 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.3K

75.07% 3M change

102.86% 12M change

Total Value Held $778,808

Alicia C Olivo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2026	SELL Payment of exercise price or tax liability	-	15,145 Reduced 16.74%	75,320 Common Stock
Jan 13 2026	BUY Exercise of conversion of derivative security	-	59,382 Added 39.63%	90,465 Common Stock
Nov 25 2025	SELL Open market or private sale	$250,992 $12.0 p/Share	20,916 Reduced 40.22%	31,083 Common Stock
Nov 25 2025	BUY Exercise of conversion of derivative security	$90,218 $10.05 p/Share	8,977 Added 14.72%	51,999 Common Stock
Oct 16 2025	SELL Open market or private sale	$49,180 $10.0 p/Share	4,918 Reduced 10.26%	43,022 Common Stock
Sep 01 2025	SELL Payment of exercise price or tax liability	-	1,666 Reduced 3.36%	47,940 Common Stock
Aug 01 2025	SELL Payment of exercise price or tax liability	-	14 Reduced 0.03%	49,606 Common Stock

May 11 2025	SELL Payment of exercise price or tax liability	-	1,584 Reduced 3.09%	49,620 Common Stock
May 11 2025	BUY Exercise of conversion of derivative security	-	6,503 Added 11.27%	51,204 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	-	652 Reduced 1.44%	44,701 Common Stock
Feb 23 2025	SELL Payment of exercise price or tax liability	-	2,504 Reduced 5.23%	45,353 Common Stock
Feb 23 2025	BUY Exercise of conversion of derivative security	-	8,443 Added 15.0%	47,857 Common Stock
Nov 15 2024	SELL Open market or private sale	$79,488 $15.36 p/Share	5,175 Reduced 12.23%	37,129 Common Stock
Sep 01 2024	SELL Payment of exercise price or tax liability	-	1,666 Reduced 3.8%	42,147 Common Stock
Aug 15 2024	SELL Open market or private sale	$16,692 $16.05 p/Share	1,040 Reduced 2.32%	43,813 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	-	14 Reduced 0.03%	44,853 Common Stock
May 15 2024	SELL Open market or private sale	$16,511 $15.74 p/Share	1,049 Reduced 2.28%	44,867 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$23,538 $14.86 p/Share	1,584 Reduced 3.86%	39,414 Common Stock
May 11 2024	BUY Exercise of conversion of derivative security	-	13,004 Added 22.07%	45,916 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	-	652 Reduced 1.86%	34,496 Common Stock
Feb 15 2024	SELL Open market or private sale	$38,701 $14.96 p/Share	2,587 Reduced 6.91%	34,866 Common Stock
Nov 17 2023	SELL Open market or private sale	$49,082 $18.39 p/Share	2,669 Reduced 6.7%	37,140 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	-	14 Reduced 0.04%	39,498 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	-	1,666 Reduced 4.06%	39,411 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	-	14 Reduced 0.03%	40,981 Common Stock

ACO

Alicia C Olivo

EVP, GC & Business Development

Fort Myers, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Value

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEOGENOMICS INC

Track Activities on NEO

Account